Abbott Laboratories (ABT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Abbott Laboratories (ABT)
Company Performance

Current Price

as of Dec 03, 2024

$116.29

P/E Ratio

35.52

Market Cap

$202.6B

Loading...
Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Metrics

Overview

  • HQAbbott Park, IL
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerABT
  • Price$116.29-0.45%

Trading Information

  • Market cap$202.60B
  • Float99.34%
  • Average Daily Volume (1m)5,008,081
  • Average Daily Volume (3m)5,073,283
  • EPS$3.30

Company

  • Revenue$41.22B
  • Rev growth (1yr)4.85%
  • Net income$1.64B
  • Gross margin51.02%
  • EBITDA margin24.63%
  • EBITDA$2.62B
  • EV$206.67B
  • EV/Revenue5.01
  • P/E35.52
  • P/S4.95
  • P/B5.09
Documents